These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26538325)

  • 1. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.
    Rodríguez-Mañero M; Sacher F; de Asmundis C; Maury P; Lambiase PD; Sarkozy A; Probst V; Gandjbakhch E; Castro-Hevia J; Saenen J; Fukushima Kusano K; Rollin A; Arbelo E; Valderrábano M; Arias MA; Mosquera-Pérez I; Schilling R; Chierchia GB; García-Bolao I; García-Seara J; Hernandez-Ojeda J; Kamakura T; Martínez-Sande L; González-Juanatey JR; Haïssaguerre M; Brugada J; Brugada P
    Heart Rhythm; 2016 Mar; 13(3):669-82. PubMed ID: 26538325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation for monomorphic ventricular tachycardia in Brugada syndrome patients: detailed characteristics and long-term follow-up.
    Tokioka S; Fukamizu S; Kitamura T; Miyazawa S; Kawamura I; Hojo R; Sakurada H; Hiraoka M
    J Interv Card Electrophysiol; 2020 Jan; 57(1):97-103. PubMed ID: 31606866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
    Zhang P; Tung R; Zhang Z; Sheng X; Liu Q; Jiang R; Sun Y; Chen S; Yu L; Ye Y; Fu G; Shivkumar K; Jiang C
    Heart Rhythm; 2016 Nov; 13(11):2151-2158. PubMed ID: 27453126
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface ECG characteristics of ventricular tachyarrhythmias before degeneration into ventricular fibrillation in patients with Brugada-type ECG.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Ohta M; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2009 Jul; 50(4):477-87. PubMed ID: 19609052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of the initiation pattern of monomorphic ventricular tachycardia.
    Gorenek B; Kudaiberdieva G; Birdane A; Goktekin O; Cavusoglu Y; Bakar S; Unalir A; Ata N; Timuralp B
    Int J Cardiol; 2004 Feb; 93(2-3):325-7. PubMed ID: 14975574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator.
    Willems S; Borggrefe M; Shenasa M; Chen X; Hindricks G; Haverkamp W; Wietholt D; Block M; Breithardt G
    Pacing Clin Electrophysiol; 1993 Aug; 16(8):1684-92. PubMed ID: 7690937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P
    J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducibility of ventricular arrhythmias after gastric distension: the catecholamine equivalent in Brugada syndrome ablation?
    Negroni MS; Bacchioni G; Dello Russo A; Gianni C
    Heart Rhythm; 2013 Oct; 10(10):1549-52. PubMed ID: 23891955
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Tassaneeyakul W; Sawanyawisuth K
    Singapore Med J; 2014 Apr; 55(4):217-20. PubMed ID: 24763838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Nademanee K; Chung FP; Sacher F; Nogami A; Nakagawa H; Jiang C; Hocini M; Behr E; Veerakul G; Jan Smit J; Wilde AAM; Chen SA; Yamashiro K; Sakamoto Y; Morishima I; Das MK; Khongphatthanayothin A; Vardhanabhuti S; Haissaguerre M
    Circulation; 2023 May; 147(21):1568-1578. PubMed ID: 36960730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
    Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
    Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
    Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitachycardia pacing for shock prevention in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    Dallaglio PD; di Marco A; Moreno Weidmann Z; Perez L; Alzueta J; García-Alberola A; Fernandez-Lozano I; Díaz-Infante E; Rodriguez A; Basterra N; Calvo D; Rodriguez Garcia M; Aceña M; Anguera I
    Heart Rhythm; 2020 Jul; 17(7):1084-1091. PubMed ID: 32113896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of cardiac pacing in ICD recipients with hypertrophic cardiomyopathy.
    Jiménez-Sánchez D; Castro-Urda V; Toquero-Ramos J; Restrepo-Córdoba MA; Sánchez-García M; García-Izquierdo E; Veloza D; Baena-Herrera J; González-López E; Domínguez F; García-Pavía P; Fernández-Lozano I
    J Interv Card Electrophysiol; 2022 Jan; 63(1):165-174. PubMed ID: 33594661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.